Menstrual Phase Endometrial Scratch in IUI Cycles

Sponsor
Carilion Clinic (Other)
Overall Status
Terminated
CT.gov ID
NCT04641598
Collaborator
(none)
57
1
2
35.1
1.6

Study Details

Study Description

Brief Summary

Patients undergoing treatment with intrauterine insemination (IUI) will be randomized to receive an endometrial scratch or sham procedure during the menstrual phase of the treatment cycle.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Endometrial Scratch
  • Procedure: Sham procedure
N/A

Detailed Description

Infertility is a common issue faced by many couples throughout the United States. There are multiple fertility treatment options, including in vitro fertilization (IVF) and intrauterine insemination (IUI). Additionally, methods such as endometrial scratch (a modified endometrial biopsy) have been postulated to increase success rate. This prospective, randomized control trial will assess whether performing an endometrial scratch improves cycle outcomes and decreases time to pregnancy following IUI. Each patient will be randomly assigned to receive either an endometrial scratch or undergo a "sham" procedure (speculum insertion but no scratch) during the menstrual phase of the IUI cycle.

Study Design

Study Type:
Interventional
Actual Enrollment :
57 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants are randomized to endometrial scratch or "sham" procedure (speculum insertion but no endometrial scratch)Participants are randomized to endometrial scratch or "sham" procedure (speculum insertion but no endometrial scratch)
Masking:
Single (Participant)
Masking Description:
Participants are not made aware of which arm they are randomized to until after the cycle outcome has been determined.
Primary Purpose:
Treatment
Official Title:
The Effect of Menstrual Phase Endometrial Scratch on Intrauterine Insemination Cycle Outcomes and Participant Acceptability
Actual Study Start Date :
Aug 31, 2018
Actual Primary Completion Date :
Aug 2, 2021
Actual Study Completion Date :
Aug 2, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Endometrial scratch

A speculum will be inserted into the vagina and the cervix cleansed with betadine (or alternative if allergy). The cervix will be grasped with a single tooth tenaculum and an endometrial biopsy pipelle inserted into the uterine cavity to the depth of the uterine fundus. Suction will be applied and the pipelle will be completely withdrawn in a single pass. All instruments will be removed from the vagina after hemostasis is ensured.

Procedure: Endometrial Scratch
An endometrial biopsy pipelle will be used to create endometrial injury in the form of a "scratch".
Other Names:
  • Endometrial injury
  • Sham Comparator: Sham procedure

    A speculum will be inserted into the vagina and the cervix cleansed with betadine (or alternative if allergy). The motions of grasping the cervix with a single tooth tenaculum and inserting the biopsy pipelle will be simulated, but not actually performed. All instruments will then be removed from the vagina.

    Procedure: Sham procedure
    Motions of performing an endometrial scratch will be performed including speculum placement and cervix cleansing, however, placement of the tenaculum and the endometrial scratch will not be performed.
    Other Names:
  • Sham
  • Outcome Measures

    Primary Outcome Measures

    1. Pregnancy rate [Within one month from study randomization.]

      Obtaining a positive pregnancy test (urine or serum) at the conclusion of the treatment cycle in which the scratch was performed.

    Secondary Outcome Measures

    1. Time to conception [To be assessed within 6 months of randomization.]

      The amount of time between study randomization and positive pregnancy test.

    2. Participants perceived acceptability [The survey assessing this outcome is completed by the participant on the day of the study procedure.]

      Participants rating of acceptability of the study procedure.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 37 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • All patients undergoing intrauterine insemination procedures between the ages of 18 and 37 who have undergone a complete fertility work up (tubal, uterine, hormonal and sperm assessments) and do not have a current tubal or uterine factor infertility or severe male factor (expected to have < 10 million total motile sperm on IUI sample) unless using donor sperm.
    Exclusion Criteria:
    • age < 18 or > 37, expectation (prior to randomization) of < 10 million total motile sperm on IUI sample, tubal factor, uterine factor, incomplete fertility work up.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Carilion Clinic Reproductive Medicine and Fertility Roanoke Virginia United States 24016

    Sponsors and Collaborators

    • Carilion Clinic

    Investigators

    • Principal Investigator: Emily E Hoeker, MD, Carilion Clinic

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Emily Evans-Hoeker, Principal Investigator, Physician, Carilion Clinic
    ClinicalTrials.gov Identifier:
    NCT04641598
    Other Study ID Numbers:
    • IRB-20-1017
    First Posted:
    Nov 24, 2020
    Last Update Posted:
    Aug 6, 2021
    Last Verified:
    Aug 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Emily Evans-Hoeker, Principal Investigator, Physician, Carilion Clinic
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 6, 2021